Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Clinical Pharmacy 2018

Welcome Message

Sessions/Tracks

Conference Series LLC  is overwhelmed and delighted to announce the inception of the novel event “5th International Conference on Clinical Pharmacy and Healthcare IT”. The most awaited event would be staged during March 30-31, 2018, at Orlando, USA. With the theme upholding “Healthy World by Pharmacist; Patient Welfare by Quality Pharmaceuticals”, the event is assured to bring forth transparent and significant changes in the Healthcare sector.

Track 1: Clinical Pharmacy

Clinical Pharmacy is the field of pharmacy practice in which Pharmacists  provides better patient care that improves medication therapy and will improve health and disease prevention. The overall goal line of clinical pharmacy is to uphold the correct and appropriate use of prescription and non-prescription medicinal products and devices, and to minimize side effects and adverse effects. Clinical Pharmacists depend on their professional relationships with patients to tailor their advice to best meet individual patient needs and desires.

Related Conferences:

5th International Pharmacy Conference September 01-02, 2017 Las Vegas, USA; 9th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 4th International Conference On clinical Trials September; 11-13, 2017 San Antonio, USA; 3rd International Conference on Advanced Clinical Research and Clinical Trials September 20-21, 2017 Dublin, Ireland; 11th International Conference on Pharmacoepidemiology and Clinical Research July 06-08, 2017 Kuala Lumpur, Malaysia; 6th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; The Clinical Pharmacy Congress May 12 -13, 2017 Excel Exhibition Centre, London, UK; Clinical Trial Conference Apr 10-12 the Grand Hyatt, Washington D.C., United States Of America; Clinical Research Professional Certification Preparation and Review Course; Clinical Trial Supply 2017 Jan 23-25

Related societies:

American Association of Colleges of Pharmacy | American Pharmacists Association | American Society of Consultant Pharmacists (ASCP) | European Association of Employed Community Pharmacists in Europe | European Pharmaceutical Union

Track 2: Healthcare Informatics

Health communication strategies and healthcare informatics used to improve population health outcomes and health care quality, and to achieve health equity. Ideas about health and behaviors are shaped by the communication, information, and technology that people interact with every day. Health communication and health information technology (IT) are central to health care, public health, and the way our society views health. These processes make up the context and the ways professionals and the public search for, understand, and use health information, significantly impacting their health decisions and actions

Related:

5th International Conference and Exhibition on Pharmacology and Ethno pharmacology, March 23-25, 2017 Orland, USA; 9th Annual European Pharma Congress, July 10-12, 2017 Madrid, Spain; 10th Asia-Pacific Pharma Congress, May 08-10, 2017 Singapore; 2nd International Conference and Exhibition on Marine Drugs & Natural Products, June 15-17, 2017 London, UK; 3rd International Conference and Expo on Drug Discovery & Designing, September 25-27, 2017 Vienna, Austria; 19th International Conference on Clinical Pharmacy and Immunology  January 19 - 20, 2017, London, United Kingdom; CBI’S Pharmaceutical Compliance Congress April 26-28, 2017,The Ritz-Carlton, Washington, DC; 19th International Conference on Clinical Pharmacy and Pharmacogenetics, January 12 - 13, 2017, Durban, South Africa; 5th International Conference and Exhibition on Pharmacognosy, Phytochemistry & Natural Products July 24-26, 2017 Melbourne, Australia; 6th Annual European Pharma Congress   July 10-12, 2017 Madrid, Spain; Active living research conference Feb 26-1 Mar 2017

Related societies:

Pharmaceutical Society of Australia | The Pharmacy Guild of Australia The Society of Hospital Pharmacists of Australia | Canadian Pharmacists Association |Canadian Society of Hospital Pharmacists Chinese Pharmaceutical Association

Track 3: Clinical Pharmacology and Toxicology

Clinical pharmacology deals with study of drugs and their clinical use. It is supported by the basic science of pharmacology, with added focus on the application of pharmacological principles and quantitative methods. It has a wide scope, from the discovery of new target molecules to the effects of drug usage in whole populations. Clinical Toxicology is processes with are involved with the different forms of toxic chemicals and they associated with the different forms of diseases. It typically coincides with other sciences like as biochemistry, pharmacology and pathology.

Related:

5th International Pharmacy Conference September 01-02, 2017 Las Vegas, USA; 9th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 4th International Conference On clinical Trials September; 11-13, 2017 San Antonio, USA; 3rd International Conference on Advanced Clinical Research and Clinical Trials September 20-21, 2017 Dublin, Ireland; 11th International Conference on Pharmacoepidemiology and Clinical Research July 06-08, 2017 Kuala Lumpur, Malaysia; 6th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; the Clinical Pharmacy Congress May 12 -13, 2017 Excel Exhibition Centre, London, UK; Clinical Trial Conference Apr 10-12 the Grand Hyatt, Washington D.C., United States Of America; Clinical Research Professional Certification Preparation and Review Course; Clinical Trial Supply 2017 Jan 23-25

Related societies:

American Association of Colleges of Pharmacy | American Pharmacists Association | American Society of Consultant Pharmacists (ASCP) | European Association of Employed Community Pharmacists in Europe | European Pharmaceutical Union

Track 4: Clinical Research

Clinical research is a part of healthcare science that determines the safety and effectiveness (efficacy) of medications, devices, diagnostic products and treatment regimens intended for human use. These may be used for prevention, treatment, diagnosis or for relieving symptoms of a disease. Clinical research is different from clinical practice. In clinical practice established treatments are used, while in clinical research evidence is collected to establish a treatment. Clinical research refers to the entire catalogue of a drug/device/biologic, in fact any test article from its inception in the lab to its introduction to the consumer market and beyond. Once the promising candidate or the molecule is identified in the lab, it is subjected to pre-clinical studies or animal studies where different aspects of the test article are studied.

Related Conferences:

5th International Conference on Clinical Pharmacy October 23-24, 2017 Orland, Florida, USA; 8th Annual Global Pharma Summit August 17-18, 2017 Los Angeles, Naveda, California, USA; 13th International Conference on Clinical Gastroenterology and Hepatology Nov 13-15, 2017 Las Vegas, USA; 14th International Conference on Clinical and Experimental Dermatology June 19-21, 2017 Philadelphia, USA

Related societies:

Clinical Pharmacy Conferences Pharma Conferences | Pharmaceutical Conferences | Kuwait Pharmaceutical Association | Pharmaceutical Association of Mauritius 

Track 5: Hospital Pharmacy

The duties of the Hospital Pharmacists is to be part of the medication management in hospitals, which encompasses the process in which medicines are selected, procured, delivered, prescribed, administered and reviewed to optimize the contribution that medicines make in generating informed and desired outcomes to enhance the safety and quality of all medicine related processes affecting patients in the hospital to ensure the 7 “rights” are respected: right patient, right dose, right route, right time, right drug with the right information and documentation.

Related Conferences:

5th International Conference on Clinical Pharmacy October 23-24, 2017 Orland, Florida, USA; 8th Annual Global Pharma Summit August 17-18, 2017 Los Angeles, Nevada, California, USA; 13th International Conference on Clinical Gastroenterology and Hepatology Nov 13-15, 2017 Las Vegas, USA; 14th International Conference on Clinical and Experimental Dermatology June 19-21, 2017 Philadelphia, USA; 10th International Congress on Clinical Virology December 4-6, 2017 Dubai, UAE; International Congress and Exhibition on Pharmacy April 03-05, 2017, Dubai, UAE; International Summit on Pharma and Clinical Trials June 12-13, 2017 Sydney, Australia; Annual World Congress on Biomarkers & Clinical Research JULY 27-28, 2017 Chicago, Illinois, USA; Clinical Innovation and Partnering World 8-9 March Hilton Tower Bridge, London; International Congress on Clinical Trials in Oncology and Hemato-Oncology June 21 - 22, 2017,Vienna, Austria

Related societies:

Pharmaceutical Society of Australia | The Pharmacy Guild of Australia The Society of Hospital Pharmacists of Australia | Canadian Pharmacists Association | Canadian Society of Hospital Pharmacists 

Track 6: Drug Information and Dosing

Drug Information provides topics relating to drug development and regulation that is of current relevance and importance, and will include the lists of proposed and recommended. The objective is to bring issues that are of primary concern to drug regulators and pharmaceutical manufacturers to the attention of a wide audience of health professionals and policy-makers concerned with the rational use of drugs. In effect, Conference seeks to relate regulatory activity to therapeutic practice. The dosage and administration includes the following categories of information for each of a drug’s indications to the extent the information is known and relevant to the safe and effective dosing and administration of the drug. For most drugs, not all categories of information described below will be available or relevant.

Related:

16th Annual Medicinal & Pharmaceutical Sciences Congress July 03-05, 2017 Kuala Lumpur, Malaysia; 9th International Conference And Exhibition On Pharmacovigilance and  Drug Safety July 17-19, 2017 Munich, Germany; World Congress On Bio Therapeutics And Bio Analytical Techniques Sep 11-13, 2017, Mexico, USA; 11th World Congress On Pharmaceutical Sciences And Innovations In Pharma Industry Feb 27-28, 2017, Amsterdam, Netherlands; 22nd Conference Of The EAHP March 22-24, 2017, Cannes, France; Hospital Pharmacy Conference May  1-3, 2017, The Westin Bonaventure Hotel & Suites, Los Angeles, USA; Pharma CI Conference And Exhibition Sep 12-13, 2017,Parsippany,Usa; World Congress On Pharma And Advanced Clinical Research 6-8 November, 2017, Singapore; 19th International Conference on Pharmacy and Pharmacokinetics , January 30 - 31, 2017, Jeddah, Saudi Arab; 9th World Congress On Pharmacology Aug 7-9, 2017, Paris, France.

Related societies:

National Pharmacy Association | Pharmaceutical Society of Northern Ireland | Royal Pharmaceutical Society | American Association of Colleges of Pharmacy | American Pharmacists Association | American Society for Pharmacy Law

Track 7:  Pharmacoeconomics

Pharmacoeconomics refers to the scientific discipline that compares the value of one pharmaceutical drug or drug therapy to another. It is a sub-discipline of health economics. A pharmacoeconomic study evaluates the cost and effects of a pharmaceutical product. Pharmacoeconomic studies serve to guide optimal healthcare resource allocation, in a standardized and scientifically grounded manner. Pharmacoeconomics centres on the economic evaluation of pharmaceuticals, and can use cost-minimization analysis, cost-benefit analysis, cost-effectiveness analysis or cost-utility analysis. Quality-adjusted life years have become the dominant outcome of interest in pharmacoeconomic evaluations, and many studies employ a cost-per-QALY analysis.

Related:

5th International Conference on Clinical Pharmacy October 23-24, 2017 Orland, Florida, USA; 8th Annual Global Pharma Summit August 17-18, 2017 Los Angeles, Naveda, California, USA; 13th International Conference on Clinical Gastroenterology and Hepatology Nov 13-15, 2017 Las Vegas, USA; 14th International Conference on Clinical and Experimental Dermatology June 19-21, 2017 Philadelphia, USA; 10th International Congress on Clinical Virology December 4-6, 2017 Dubai, UAE; International Congress and Exhibition on Pharmacy April 03-05, 2017, Dubai, UAE; International Summit on Pharma and Clinical Trials   June 12-13, 2017 Sydney, Australia; Annual World Congress on Biomarkers & Clinical Research JULY 27-28, 2017 Chicago, Illinois, USA; Clinical Innovation and Partnering World 8-9 March Hilton Tower Bridge, London; International Congress on Clinical Trials in Oncology and Hemato-Oncology June 21 - 22, 2017,Vienna, Austria

Related societies:

Pharmaceutical Society of Australia | The Pharmacy Guild of Australia The Society of Hospital Pharmacists of Australia | Canadian Pharmacists Association |Canadian Society of Hospital Pharmacists Chinese Pharmaceutical Association

Track 8:  Community Pharmacy

A community pharmacy is a healthcare facility that emphasizes providing pharmaceutical services to a specific community. Typically, a registered pharmacist dispenses medicine from the community pharmacy. Community-based pharmacists responsibilities include: checking and dispensing of prescription drugs, providing advice on drug selection and usage to doctors and other health professionals and counseling patients in health promotion, disease prevention and the proper use of medicines. In most countries regulations govern how dispensaries may operate, with specific requirements for storage conditions, equipment and record keeping.

Related:

12th World Pharma Congress October 16-18, 2017 Budapest, Hungary; 12th Annual Pharma Middle East Congress Sep 25-27, 2017 Dubai, UAE; 7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR Sep 25-26, 2017 Chicago, USA; 10th Asia-Pacific Pharma Congress May 08-10, 2017 Singapore; 2nd International Conference on Clinical Chemistry and Laboratory Medicine September 28-29, 2017 Atlanta, USA; Drug Discovery and Therapy world congress 2017 July 10- 13 Boston, USA; Canadian Pharmacists Conference 2017 June 2-5 Quebec city; International summit on Pharma and clinical trials   June 12-13,2017 Sydney, Australia; Clinical Operations in Oncology Trials East Coast 2017

Related societies:

Royal Pharmaceutical Society |  American Association of Colleges of Pharmacy | American Pharmacists Association (APHA) | American Society for Pharmacy Law | American Pharmacists Association

Track 9:  Pharmacy Informatics

Pharmacy informatics is the scientific field that focuses on medication-related data and knowledge within the continuum of healthcare systems - including its acquisition, storage, analysis, use and dissemination - in the delivery of optimal medication-related patient care and health outcomes.  It is the application of computers to the storage, retrieval and analysis of drug and prescription information. Pharmacy informatics can be thought of as a sub-domain of the larger professional discipline of healthcare informatics. Health informatics is the study of interactions between people, their work processes and engineered systems within health care with a focus on pharmaceutical care and improved patient safety.  Pharmacy informaticists work with pharmacy information management systems that help the pharmacist safe decisions about patient drug therapies with respect to, medical insurance records, drug interactions, as well as prescription and patient information.

Related:

5th International Conference and Exhibition on Pharmacology and Ethno pharmacology, March 23-25, 2017 Orland, USA; 9th Annual European Pharma Congress, July 10-12, 2017 Madrid, Spain; 10th Asia-Pacific Pharma Congress, May 08-10, 2017 Singapore; 2nd International Conference and Exhibition on Marine Drugs & Natural Products, June 15-17, 2017 London, UK; 3rd International Conference and Expo on Drug Discovery & Designing, September 25-27, 2017 Vienna, Austria; 19th International Conference on Clinical Pharmacy and Immunology  January 19 - 20, 2017, London, United Kingdom

Related societies:

Clinical Pharmacy Conferences Pharma Conferences | Pharmaceutical Conferences | Kuwait Pharmaceutical Association | Pharmaceutical Association of Mauritius 

Track 10:  Industrial Pharmacy

Industrial Pharmacy is a discipline which includes manufacturing, development, marketing and distribution of drug products including quality assurance of these activities. This broad research area relates to different functions in pharmaceutical industry and having contact areas with engineering and economics.

Related:

CBI’S Pharmaceutical Compliance Congress April 26-28, 2017,The Ritz-Carlton, Washington, DC; 19th International Conference on Clinical Pharmacy and Pharmacogenetics , January 12 - 13, 2017, Durban, South Africa; 5th International Conference and Exhibition on Pharmacognosy, Phytochemistry & Natural Products July 24-26, 2017 Melbourne, Australia; 6th Annual European Pharma Congress   July 10-12, 2017 Madrid, Spain; Active living research conference Feb 26-1 Mar 2017

Related societies:

Pharmaceutical Society of Australia | The Pharmacy Guild of Australia The Society of Hospital Pharmacists of Australia | Canadian Pharmacists Association |Canadian Society of Hospital Pharmacists Chinese Pharmaceutical Association

Track 11:  Pharmaceutical Care

Pharmaceutical care is the responsible provision of drug therapy for the purpose of achieving definite outcomes that improve a patient's quality of life. These outcomes are cure of a disease; elimination or reduction of a patient's symptomatology; arresting or slowing of a disease process; or preventing a disease or symptomatology. Pharmaceutical care involves the process through which a pharmacist cooperates with a patient and other professionals in designing, implementing, and monitoring a therapeutic plan that will produce specific therapeutic outcomes for the patient. Pharmaceutical care is a necessary element of health care and should be integrated with other elements.  It is provided for the direct benefit of the patient and the pharmacist is responsible directly to the patient for the quality of that care.

Related:

8th World Congress on Bioavailability and Bioequivalence: BA/BE Studies Summit June 26-28, 2017 San Diego, USA; 7th Global Experts Meeting on Neuropharmacology, July 31-Aug 02, 2017 Milan, Italy; 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, March 13-15, 2017 London, UK; 6th Global Experts Meeting on Cardiovascular Pharmacology and Cardiac Medications, April 13-14, 2017 Dubai, UAE; 8th World Congress on Pharmacology and Toxicology, July 24-26, 2017 Melbourne, Australia; Pharmacovigilance Europe 2017 23-24 May 2017,London,UK; 19th International Conference on Clinical Drug Developments and Pharmacovigilance January 23 - 24, 2017, Amsterdam, Netherlands; 19th International Conference on Clinical Immunology,  Pharmacy and Drug Development  January 26 - 27, 2017, Innsbruck, Austria.

Related societies:

American Society for Pharmacy Law | American Society of Consultant Pharmacists | American Society of Consultant Pharmacists Foundation | American Society of Health-System Pharmacists | Professional Compounding centers of America

Track 12:  Drug Safety and Efficacy

Drug safety or it is also known as Pharmacovigilence is the pharmacological science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products. Pharmacovigilance heavily focuses on adverse drug reactions, or ADRs, which are defined as any response to a drug which is noxious and unintended, including lack of efficacy the condition that this definition only applies with the doses normally used for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological disorder function was excluded with the latest amendment of the applicable legislation. Medication errors such as overdose, and misuse and abuse of a drug as well as drug exposure during pregnancy and breastfeeding, are also of interest, even without an adverse event, because they may result in an adverse drug reaction.

Related:

9th Annual European Pharma Congress, July 10-12, 2017 Madrid, Spain; 10th Asia-Pacific Pharma Congress, May 08-10, 2017 Singapore; 2nd International Conference and Exhibition on Marine Drugs & Natural Products, June 15-17, 2017 London, UK; 3rd International Conference and Expo on Drug Discovery and Designing, September 25-27, 2017 Vienna, Austria.

Related societies:

Pharmaceutical Society Of New Zealand Norwegian Pharmacy Association |  American Pharmacists Association | National Pharmacy Association | Pharmaceutical Society of Northern Ireland | Royal Pharmaceutical Society | American Association of Colleges of Pharmacy

Track 13: Nuclear Pharmacy

Nuclear pharmacy is a specialty area of pharmacy practice dedicated to the compounding and dispensing of radioactive materials for use in nuclear medicine procedures.  A specialty area of pharmacy practice is one that requires a concentration of knowledge in a once specific area. Radiopharmacology is a radiochemistry applied to medicine and thus the pharmacology of radiopharmaceuticals. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases.

Related:

5th International Conference and Exhibition on Pharmacology and Ethno pharmacology, March 23-25, 2017 Orland, USA; 9th Annual European Pharma Congress, July 10-12, 2017 Madrid, Spain; 10th Asia-Pacific Pharma Congress, May 08-10, 2017 Singapore; 2nd International Conference and Exhibition on Marine Drugs & Natural Products, June 15-17, 2017 London, UK; 3rd International Conference and Expo on Drug Discovery & Designing, September 25-27, 2017 Vienna, Austria; 19th International Conference on Clinical Pharmacy and Immunology  January 19 - 20, 2017, London, United Kingdom; CBI’S Pharmaceutical Compliance Congress April 26-28, 2017,The Ritz-Carlton, Washington, DC; 19th International Conference on Clinical Pharmacy and Pharmacogenetics, January 12 - 13, 2017, Durban, South Africa; 5th International Conference and Exhibition on Pharmacognosy, Phytochemistry & Natural Products July 24-26, 2017 Melbourne, Australia; 6th Annual European Pharma Congress   July 10-12, 2017 Madrid, Spain; Active living research conference Feb 26-1 Mar 2017

Related societies:

Pharmaceutical Society of Australia | The Pharmacy Guild of Australia The Society of Hospital Pharmacists of Australia | Canadian Pharmacists Association |Canadian Society of Hospital Pharmacists Chinese Pharmaceutical Association

Track 14: Drug Utilization

Drug Utilizations deals with study of Prescription, dispensing, ingesting, marketing, distribution, and use of drugs in a society, with special emphasis on the resulting medical, social and economic consequences.  It is interrelated to Epidemiology, Pharmacoepidemiology, Pharmacosurveillance and pharmacovigilance. Drug utilization research is thus an essential part of pharmacoepidemiology as it describes the extent, nature and determinants of drug exposure. Over time, the distinction between these two terms has become less sharp, and they are sometimes used interchangeably.

Related:

16th Annual Medicinal & Pharmaceutical Sciences Congress July 03-05, 2017 Kuala Lumpur, Malaysia; 9th International Conference And Exhibition On Pharmacovigilance and  Drug Safety July 17-19, 2017 Munich, Germany; World Congress On Bio Therapeutics And Bio Analytical Techniques Sep 11-13, 2017, Mexico, USA; 11th World Congress On Pharmaceutical Sciences And Innovations In Pharma Industry Feb 27-28, 2017, Amsterdam, Netherlands; 22nd Conference Of The EAHP March 22-24, 2017, Cannes, France; Hospital Pharmacy Conference May  1-3, 2017, The Westin Bonaventure Hotel & Suites, Los Angeles, USA; Pharma CI Conference And Exhibition Sep 12-13, 2017,Parsippany,Usa; World Congress On Pharma And Advanced Clinical Research 6-8 November, 2017, Singapore; 19th International Conference on Pharmacy and Pharmacokinetics , January 30 - 31, 2017, Jeddah, Saudi Arab; 9th World Congress On Pharmacology Aug 7-9, 2017, Paris, France.

Related societies:

National Pharmacy Association | Pharmaceutical Society of Northern Ireland | Royal Pharmaceutical Society | American Association of Colleges of Pharmacy | American Pharmacists Association | American Society for Pharmacy Law

Track 15: Disease Management Programs

Disease management programs (DMPs) are structured treatment plans that aim to help people better manage their chronic disease and to maintain and improve quality of life. People with chronic conditions generally use more health care services, including physician visits, hospital care, and prescription drugs. Increases in the number of people living longer with chronic conditions coupled with rising health care expenditures have spurred health plans, employers, and the government to look for ways to reduce health care use and costs. Disease management programs are designed to improve the health of persons with specific chronic conditions and to reduce health care service use and costs associated with avoidable complications.


Related:

8th World Congress on Bioavailability and Bioequivalence: BA/BE Studies Summit June 26-28, 2017 San Diego, USA; 7th Global Experts Meeting on Neuropharmacology, July 31-Aug 02, 2017 Milan, Italy; 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, March 13-15, 2017 London, UK; 6th Global Experts Meeting on Cardiovascular Pharmacology and Cardiac Medications, April 13-14, 2017 Dubai, UAE; 8th World Congress on Pharmacology and Toxicology, July 24-26, 2017 Melbourne, Australia; Pharmacovigilance Europe 2017 23-24 May 2017,London,UK; 19th International Conference on Clinical Drug Developments and Pharmacovigilance January 23 - 24, 2017, Amsterdam, Netherlands; 19th International Conference on Clinical Immunology,  Pharmacy and Drug Development  January 26 - 27, 2017, Innsbruck, Austria.

Related societies:

American Society for Pharmacy Law | American Society of Consultant Pharmacists | American Society of Consultant Pharmacists Foundation | American Society of Health-System Pharmacists | Professional Compounding centers of America

Track 16: Applied Pharmacogenomics and Therapeutics

Pharmacogenomics is the study of the role of the genome in drug response. It deals with the study of the technology that analyzes how the genetic makeup of an individual affects response to drugs and influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacokinetics and pharmacodynamics (drug absorption, distribution, metabolism, and elimination) as well as drug receptor target effects. Pharmacogenomics is often used interchangeably with pharmacogenetics. Although both terms relate to drug response based on genetic influences, pharmacogenetics focuses on single drug-gene interactions, while pharmacogenomics encompasses a more genome-wide association approach, incorporating genomics and epigenetics while dealing with the effects of multiple genes on drug response.

Related:  

2nd International Conference on Nuclear Medicine & Radiation Therapy July 27-28, 2017 Rome, Italy; 9th Annual European Pharma Congress July 10-12, 2017 Madrid, Spain; 11th Annual Global Pharma Summit August 17-18, 2017 San Francisco, USA; 12th Annual Pharma Middle East Congress Sep 25-27, 2017 Dubai, UAE; 2nd International Pharmacy Conference, April 27-28, 2017 Las Vegas, Nevada, United States of America.  ; 19th International Conference on Pharmacy and Pharmaceutical Sciences, January 30 - 31, 2017, Dubai, UAE

Related societies:

Pharmaceutical Society Of New Zealand | Norwegian Pharmacy Association |  American Pharmacists AssociationNational Pharmacy Association | Pharmaceutical Society of Northern Ireland Royal Pharmaceutical Society | American Association of Colleges of Pharmacy

About Conference


Conference Series LLC  is overwhelmed and delighted to announce the inception of the novel event “5th International Conference on Clinical Pharmacy and Healthcare IT”. The most awaited event would be staged during March 30-31, 2018, at Orlando, USA. With the theme upholding “Healthy World by Pharmacist; Patient Welfare by Quality Pharmaceuticals”, the event is assured to bring forth transparent and significant changes in the Healthcare sector.

Scope of Clinical Pharmacy:

Clinical pharmacy is a branch of pharmacy which deals with the patient care and medication and promotes health, wellness and disease inhibition. The pharmacist works in management with the doctors for the patient healthcare. Clinical pharmacists have wide education in the biomedical, pharmaceutical, and clinical sciences. Clinical Pharmacy consist of all the services accomplished by pharmacists practicing in hospitals, community pharmacies, nursing homes, home-based care services, clinics and any other setting wherever medicines are prescribed and used. The term "clinical" does not necessarily suggest an action implemented in a hospital setting. It defines that the type of activity is connected to the health of the patients. This suggests that community pharmacists and hospital pharmacists both can accomplish clinical pharmacy activities.

Overview:

The conference is gearing up for an exciting and informative program which include Keynote, plenary lectures, symposia, workshops on a variety of topics, poster presentations and various training programs for participants from all over the world covering all the latest aspects of Clinical Pharmacy.

Why Orlando?

Orlando Health is one of Florida's most comprehensive private, not-for-profit healthcare networks, and is based in Orlando, FL. Orlando Health is a $2.6 billion not-for-profit health care and a community-based network of physician practices, hospitals, and outpatient care centers throughout Central Florida. More than 2,000 physicians have privileges at Orlando Health, which is also one of the area’s largest employers with more than 18,000 employees who support our philosophy of providing high quality care and service that revolves around patients’ needs.  Every day, 100,000 inpatient admissions and nearly 900,000 outpatient visits each year.   In all, Orlando Health serves 1.8 million Central Florida residents and more than 4,500 international patients annually.  Additionally, Orlando Health provides more than $204 million in support of community health needs. The median annual Clinical Pharmacist salary in Orlando, FL is $105,998, as of January 30, 2017, with a range usually between $97,853-$114,484 not including bonus and benefit information and other factors that impact base pay.

Target Audience:

Pharmacists from various areas

Eminent Scientific Professionals in Pharma

Pharma Colleges & Training Institutes

Pharmaceutical Associations and Societies

Pharmaceutical Business Entrepreneurs

Manufacturing Pharmaceutical products Companies

Manufacturing Medical Devices Companies

Professors, Associate Professors, Assistant Professors

PhD Scholars, Graduates and Post Graduates in Pharmacy

Directors, CEO’s of Organizations

Association, Association presidents and professionals

Noble laureates in Health Care and Medicine

Data Management Companies

Market Analysis

Investment on Vaccines around globe: 

Vaccine technologies global market reached $33.3 billion in 2016 and expected to reach $45.2 billion by 2021, growing at a compound annual growth rate (CAGR) of 6.3% from 2016 to 2021. Cancer vaccines global market estimated at nearly $4.2 billion and $4.0 billion in 2014 and 2016, respectively. This market is expected to down from nearly $3.5 billion in 2016 to $3.4 billion in 2021 at a CAGR of -0.4% for 2016-2021.The global market for antithrombotic/anticoagulant drugs should reach $27.3 billion by 2021 from $18.9 billion in 2016 at a compound annual growth rate (CAGR) of 7.6%, from 2016 to 2021.

Investment on Antibiotics around globe:

Global market of advanced drug delivery is expected to grow from approximately $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%. Global Market of systemic antibiotics is expected to reach nearly $44.7 billion in 2020 from roughly $40.6 billion in 2015 at a compound annual growth rate (CAGR) of 2.0% from 2015 to 2020.

Investment on Therapeutic drugs around globe:

The global market of orphan drug totaled nearly $123 billion in 2014 and will expected to reach nearly $191 billion by 2019, demonstrating a compound annual growth rate (CAGR) of 9.2% during the forecast period (2014 to 2019). The global ophthalmic therapeutic drug market was valued at $12.3 billion in 2014. This market is expected to reach $19 billion by 2019, with a compound annual growth rate (CAGR) of 9.1% from 2014 to 2019. The global drug of abuse (DOA) testing market reached nearly $2.8 billion in 2014. This market is estimated to grow at a compound annual growth rate (CAGR) of 4.5% to reach almost $3.5 billion by 2019.

Investment on antibiotic, antibodies and generic drugs around globe:

Global market of systemic antibiotics valued at $39.6 billion in 2013 and predicted to reach $41.2 billion by 2018, at a CAGR of 0.8%. The global market for ADC drugs reached $0.179 billion in 2012 and $0.396 billion in 2013. The global market expected to reach $2800 million in 2018 with a compound annual growth rate (CAGR) of 48.1%. The global generics sector reached $269.8 billion in 2012. This sector is anticipated to reach $300.9 billion in 2013 and $518.5 billion in 2018, with a compound annual growth rate (CAGR) of 11.5%.

DISCLAIMER: 
The information developed in this report is intended only for the purpose of understanding the scope of hosting related international meetings at the respective locations. This information does not constitute managerial, legal or accounting advice, nor should it be considered as a corporate policy guide, laboratory manual or an endorsement of any product, as much of the information is speculative in nature. Conference Organizers take no responsibility for any loss or damage that might result from reliance on the reported information or from its use.

Past Conference Report

Clinical Pharmacy 2016

Thanks to all of our wonderful Speakers, Conference Attendees and Sponsors; Clinical Pharmacy 2016 Conference was our best ever!

4th International Conference  on Clinical Pharmacy hosted by the Conference Series LLC was held during November 07-09, 2016 Las Vegas, USA at Doubletree by Embassy Suites by Hilton Las Vegas, with the theme “Development, Innovative Techniques and Advanced Practices in Clinical Pharmacy” which got elaborate response. With the support and guidance of Organizing Committee Members and Editorial Board Members and stagger presentations of all participants makes the event more spectacular.

Conference Series LLC would like to convey a great appreciation to following honorable guests and speakers.

Stefan Bughi, Rancho Los Amigos National Rehabilitation Center, USA

Roseane M. Santos, South University School of Pharmacy, USA

Sabah Akrawi, King Faisal University, Saudi Arabia

Ayman Noreddin, Chapman University, USA

Gaku Fukuhara, Osaka University, Japan

Emma Yeritsyan, Yerevan State Medical University, Armenia

Honorable guests and Speakers who supported for the success of this event with imperishable excitement for grand success of this prominent conference it is glad to announce next annual meeting 5th International Conference on Clinical Pharmacy to be held during October 23-24, 2017 Florida, USA with the theme “Exploring the new challenges in clinical pharmacy.”

We hope your favorable support will make next annual also one more grand success event.

For Clinical Pharmacy 2017 PS: http://clinicalpharmacy.pharmaceuticalconferences.com/

 

 


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date March 30-31, 2018

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Clinical Pharmacology & Biopharmaceutics Clinical & Experimental Pharmacology Journal of Pharmaceutical Care & Health Systems Journal of Pharmaceutics & Drug Delivery Research

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

What People Say....

Thank you very much for inviting me to this great conference. I was very happy to hear other researchers’ topic.

Speaker

Gaku Fukuhara, Osaka University, Japan

We all enjoyed participation to this educational forum, the networking and the exchange of information with our peers from the global community and look forward to participate at future meetings.

Speaker

Stefan Bughi, Rancho Los Amigos National Rehabilitation Center, USA

Thank you for nice conference. I have met many interesting people and got many new contacts

Speaker

Dalibor Cerny, Hospital Na Homolce, Czech Republic

Thanks a lot for the opportunity of participation to such a great conference. It was well organized and I was also very much excited to be speaker at the conference. I will do my best again to participate to upcoming conferences

Speaker

Emma Yeritsyan, Yerevan State Medical University, Armenia